Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 219

2.
4.

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.

Monath TP, Soike K, Levenbook I, Zhang ZX, Arroyo J, Delagrave S, Myers G, Barrett AD, Shope RE, Ratterree M, Chambers TJ, Guirakhoo F.

Vaccine. 1999 Apr 9;17(15-16):1869-82.

PMID:
10217584
5.
6.

Immunogenicity of a purified fragment of 17D yellow fever envelope protein.

Brandriss MW, Schlesinger JJ, Walsh EE.

J Infect Dis. 1990 Jun;161(6):1134-9.

PMID:
1693159
8.

Examination of the envelope glycoprotein of yellow fever vaccine viruses with monoclonal antibodies.

Barrett AD, Pryde A, Medlen AR, Ledger TN, Whitby JE, Gibson CA, DeSilva M, Groves DJ, Langley DJ, Minor PD.

Vaccine. 1989 Aug;7(4):333-6.

PMID:
2479185
9.

Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies.

Gould EA, Buckley A, Cammack N, Barrett AD, Clegg JC, Ishak R, Varma MG.

J Gen Virol. 1985 Jul;66 ( Pt 7):1369-82.

PMID:
2410549
10.
11.

Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain).

Lobigs M, Dalgarno L, Schlesinger JJ, Weir RC.

Virology. 1987 Dec;161(2):474-8.

PMID:
2446422
14.

Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine.

Poland JD, Calisher CH, Monath TP, Downs WG, Murphy K.

Bull World Health Organ. 1981;59(6):895-900.

15.

Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies.

Buckley A, Gould EA.

J Gen Virol. 1985 Dec;66 ( Pt 12):2523-31.

PMID:
2999305
16.

Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine.

Mason RA, Tauraso NM, Spertzel RO, Ginn RK.

Appl Microbiol. 1973 Apr;25(4):539-44.

17.

Human antibody response to immunization with 17D yellow fever and inactivated TBE vaccine.

Kayser M, Klein H, Paasch I, Pilaski J, Blenk H, Heeg K.

J Med Virol. 1985 Sep;17(1):35-45.

PMID:
2995571
18.

Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice.

Bassi MR, Larsen MA, Kongsgaard M, Rasmussen M, Buus S, Stryhn A, Thomsen AR, Christensen JP.

PLoS Negl Trop Dis. 2016 Feb 17;10(2):e0004464. doi: 10.1371/journal.pntd.0004464. eCollection 2016 Feb.

19.
20.

Detection of yellow fever virus in serum by enzyme immunoassay.

Monath TP, Nystrom RR.

Am J Trop Med Hyg. 1984 Jan;33(1):151-7.

PMID:
6364854

Supplemental Content

Support Center